| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin)  |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.39 － ? |
Carbenicillin (Pyopen, Geogen, Geocillin) |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.5 － ? |
Ampicillin (Omnipen) |
349 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.5 － ? |
Cefmetazole |
349 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
0.5 － ? |
Ofloxacin (Floxin) |
332 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
1 － ? |
Cefoxitin (Mefoxin) |
349 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
1 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
349 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
2 － ? |
Metronidazole (Flagyl) |
105 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 － ? |
SCE-129 |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 － ? |
SCE-129 |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 － ? |
SCE-129 |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 － ? |
SCE-129 |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 － ? |
SCE-129 |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
3.13 － ? |
SCE-129 |
616 |
| Staphylococcus aureus (FDA 209P) |
- |
- |
4 － ? |
Piperacillin (Pipracil) |
349 |
| Staphylococcus aureus (flq(B)) |
- |
- |
0.1 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
461 |
| Staphylococcus aureus (flq(B)) |
- |
- |
0.5 － ? |
Gatifloxacin (Tequin) |
461 |
| Staphylococcus aureus (flq(B)) |
- |
- |
16 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
461 |
| Staphylococcus aureus (flq(B)) |
- |
- |
16 － ? |
Norfloxacin (Noroxin) |
461 |
| Staphylococcus aureus (flq(B)) |
- |
- |
32 － ? |
Ethidium bromide (EtBr) |
461 |
| Staphylococcus aureus (fluoroquinolone-resistant) |
- |
4 |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
66 |
| Staphylococcus aureus (fluoroquinolone-resistant) |
- |
12 |
? － ? |
Gatifloxacin (Tequin) |
66 |
| Staphylococcus aureus (fluoroquinolone-resistant) |
- |
32 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
66 |
| Staphylococcus aureus (fluoroquinolone-resistant) |
- |
64 |
? － ? |
Ofloxacin (Floxin) |
66 |
| Staphylococcus aureus (fluoroquinolone-resistant) |
- |
128 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
66 |
| Staphylococcus aureus (fluoroquinolone-susceptible) |
- |
0.047 |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
66 |
| Staphylococcus aureus (fluoroquinolone-susceptible) |
- |
0.38 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
66 |
| Staphylococcus aureus (fluoroquinolone-susceptible) |
- |
0.5 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
66 |